Anavex Life Sciences Corp (AVXL)

[crescentmotor]

First that $121 million is supposed to be enough to last 4 years assuming no additional income.

AVXL certainly hasn't made that statement. Here is the most current guidance: "Management believes that the current working capital position will be sufficient to meet the Company’s working capital requirements beyond the next 12 months after the date that these condensed consolidated interim financial statements are issued." If the EMA or the FDA were to require additional trials involving Rett Syndrome or 2-73 for AD, the $121 million would become vastly inadequate in short order.

Second Anavex has been able to sell shares via the ATM and there is no reason to think that won't continue as a way to raise money as needed.

You're maintaining that significant dilution selling shares at $4.50 constitutes a viable/justifiable way to raise money? I don't think so.

Forth Anavex is not in a shaky position.

Until and unless regulatory approval from either the EMA or the FDA within a year or so for AD appears likely, I'll stick with my opinion that AVXL is in a shaky position.

Then there is FTD and PD trials to get started.

Sure--expecting that soon? I think not.